USPTO serial 98634895
PROTEIN NANO FACTORY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- HA, PAULINE T.
- Law office
- TMO LAW OFFICE 115
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PROTEIN NANO FACTORY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Bioreactor for cell culturing; Bioreactors for cell culturing for scientific research; Bioreactors for laboratory use; Diagnostic apparatus for testing food; Filters used in scientific and forensic apparatus in drug detection processes; Gas testing instruments; Imaging apparatus and instruments for the study of proteins for agricultural purposes; Imaging apparatus and instruments for use in the study of proteins and peptides in drug development; Laboratory apparatus and chromatography systems for use in protein purification; Laboratory apparatus and computer systems for use in protein purification; Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Scientific apparatus, namely, spectrophotometer for measuring relative DNA, RNA and protein; Semiconductor testing apparatus | ACTIVE | — |
| 042 | Drug discovery services; Drug screening for forensic purposes; Drug screening for scientific research purposes; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Research and development in the field of biochemistry; Research and development in the field of biotechnology; Research and development in the field of diagnostic preparations; Research and development in the field of microorganisms and cells; Research and development in the pharmaceutical and biotechnology fields; Research and development of medicines; Research and development of new products; Research and development of new products for others; Research and development of pharmaceutical preparations for treating malignant tumours; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of power conversion; Research and development of vaccines; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research and development services in the field of biotechnology; Research and development services in the field of chemistry; Research and development services in the field of cosmetics; Research and development services in the field of cytology; Research and development services in the field of diagnostic preparations; Research and development services in the field of engineering; Research and development services in the field of food; Research and development services in the field of gene expression systems; Research and development services in the field of genomics; Research and development services in the field of immunohistology; Research and development services in the field of immunology; Research and development services in the field of medical preparations; Research and development services in the field of microorganisms and cells; Research and development services in the field of nutritional supplements; Research and development services in the field of pharmaceutical preparations; Research and development services of new pharmaceutical products; Research and development services relating to medicines; Research and development services relating to vaccines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing of chemicals; Testing of cosmetics; Testing of materials; Testing of pharmaceuticals; Bacteriological research and testing; Biochemical research and development; Biochemical research and development services; Consulting services in the field of pharmaceutical research and development; Environmental testing and inspection services; Laboratory testing of materials; Material testing and analysis; Material testing services; Materials testing; Materials testing services; Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical drug development services; Product research and development; Product testing; Product quality testing services; Product safety testing; Product safety testing services; Research and development of mRNA drugs; Research and development of siRNA drugs; Scientific research and development; Vaccine research and development; Vaccine research and development services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 16, 2025 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 16, 2025 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 30, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 22, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 14, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 5, 2024 | NWAP | NEW APPLICATION ENTERED | — |